Welcome to LookChem.com Sign In|Join Free
  • or
Flavanone acetylhydrazone is a chemical compound derived from flavanones, which are a subgroup of flavonoids found in various plants. These compounds are known for their antioxidant properties and potential health benefits. Flavanone acetylhydrazone, in particular, is formed by the reaction of a flavanone with an acetylhydrazine group, resulting in a new molecule with unique chemical properties. flavanone acetylhydrazone has been studied for its potential applications in pharmaceuticals and as a synthetic intermediate in the preparation of other bioactive molecules. The structure of flavanone acetylhydrazone allows for the exploration of its chemical reactivity and potential interactions with biological targets, making it an interesting subject of research in the field of natural product chemistry and drug development.

1036-36-8

Post Buying Request

1036-36-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1036-36-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1036-36-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,3 and 6 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1036-36:
(6*1)+(5*0)+(4*3)+(3*6)+(2*3)+(1*6)=48
48 % 10 = 8
So 1036-36-8 is a valid CAS Registry Number.

1036-36-8Upstream product

1036-36-8Relevant academic research and scientific papers

Compounds with NS3 serine proteinase inhibitory activity and application thereof

-

Paragraph 0063; 0068; 0069; 0070; 0071; 0072; 0074, (2017/11/18)

The invention specifically relates to compounds with NS3 serine proteinase inhibitory activity and application thereof, belonging to the field of chemical pharmacy. The invention discloses the compounds with NS3 serine proteinase inhibitory activity or pharmaceutically acceptable salts, mesomers, racemates, enantiomers, diastereomers or mixtures thereof. The structure of the compounds is as shown in the general formula (I) which is described in the specification; and the compounds comprise compounds as shown in a general formula (II) which is described in the specification, or compounds as shown in a general formula (III) which is described in the specification, or pharmaceutically acceptable salts, mesomers, racemates, enantiomers, diastereomers or mixtures thereof. Results of antiviral activity tests show that the compounds have good NS3 serine protease inhibitory activity, have the potential of being developed into novel NS3 serine protease inhibitors, and can be applied to preparation of drugs for preventing, handling and treating flavivirus infective diseases caused by hepatitis C viruses, Dengue viruses and/or West Nile viruses.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1036-36-8